Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (52) 52
humans (43) 43
stroke (39) 39
male (33) 33
clinical neurology (31) 31
female (30) 30
peripheral vascular disease (30) 30
aged (27) 27
neurosciences (25) 25
medicine & public health (23) 23
middle aged (23) 23
hematology (20) 20
thrombolysis (20) 20
stroke - drug therapy (19) 19
acute ischemic-stroke (18) 18
aged, 80 and over (18) 18
neurology (17) 17
retrospective studies (17) 17
cardiology (15) 15
ischemia (13) 13
treatment outcome (13) 13
anticoagulants (11) 11
association (11) 11
atrial fibrillation (11) 11
thrombolytic therapy - methods (10) 10
analysis (9) 9
intravenous thrombolysis (9) 9
ischemic stroke (9) 9
tissue-plasminogen activator (9) 9
alteplase (8) 8
brain ischemia - drug therapy (8) 8
care and treatment (8) 8
fibrinolytic agents - therapeutic use (8) 8
guidelines (8) 8
mortality (8) 8
neuroradiology (8) 8
thrombolytic therapy (8) 8
time factors (8) 8
cardiac & cardiovascular systems (7) 7
hemorrhage (7) 7
metaanalysis (7) 7
outcome (7) 7
patients (7) 7
risk (7) 7
risk factors (7) 7
therapy (7) 7
tissue plasminogen activator - therapeutic use (7) 7
anticoagulants - therapeutic use (6) 6
disease (6) 6
health aspects (6) 6
intracerebral hemorrhage (6) 6
psychiatry (6) 6
stroke - complications (6) 6
stroke - therapy (6) 6
thrombectomy (6) 6
warfarin (6) 6
management (5) 5
neurosurgery (5) 5
nomogram (5) 5
outcomes (5) 5
stroke - etiology (5) 5
tissue plasminogen activator - adverse effects (5) 5
trial (5) 5
usage (5) 5
acute stroke (4) 4
administration, intravenous (4) 4
administration, oral (4) 4
adult (4) 4
atrial fibrillation - complications (4) 4
brain ischemia - epidemiology (4) 4
classification (4) 4
cohort studies (4) 4
data processing (4) 4
endovascular treatment (4) 4
fibrinolytic agents - administration & dosage (4) 4
hemorrhagic transformation (4) 4
intravenous administration (4) 4
ischemic-stroke (4) 4
multivariate analysis (4) 4
patient outcomes (4) 4
prognosis (4) 4
prospective studies (4) 4
recurrence (4) 4
severity of illness index (4) 4
acute disease (3) 3
anticoagulants - adverse effects (3) 3
atrial fibrillation - drug therapy (3) 3
cardiovascular system & cardiology (3) 3
cerebral hemorrhage - epidemiology (3) 3
contraindications (3) 3
direct oral anticoagulants (3) 3
echocardiography (3) 3
factor xa inhibitors - therapeutic use (3) 3
fibrinolytic agents - adverse effects (3) 3
follow-up studies (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
infusions, intravenous (3) 3
neurovetenskaper (3) 3
nomograms (3) 3
retrospective analysis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Does monitoring of cholesterol levels is required in the acute phase after stroke thrombolysis in statin users?
by Cappellari, Manuel
Journal of the Neurological Sciences, ISSN 0022-510X, 2011, Volume 312, Issue 1, pp. 196 - 196
Neurology | INTRAVENOUS THROMBOLYSIS | PROFILE | HEMORRHAGE | NEUROSCIENCES | CLINICAL NEUROLOGY | ACUTE ISCHEMIC-STROKE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Number of ischemic strokes potentially eligible for revascularization treatments in an Italian Comprehensive Stroke Center: a modeling study
by Forlivesi, Stefano and Bonetti, Bruno and Cappellari, Manuel
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 10/2018, Volume 46, Issue 3, pp. 427 - 430
To rationally plan acute services, the proportion of ischemic strokes that may be eligible for revascularization treatments should be estimated. We aimed to... 
Thrombectomy | Eligibility | Medicine & Public Health | Hematology | Ischemic stroke | Cardiology | Thrombolysis | Guidelines | PERIPHERAL VASCULAR DISEASE | ENDOVASCULAR THROMBECTOMY | HEMATOLOGY | Stroke (Disease) | Medicine, Experimental | Medical research | Models | Ischemia | Analysis | Cardiovascular system | Stroke | Intravenous administration | Data processing | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Early use of direct oral anticoagulants after TIA/stroke in patients with atrial fibrillation: a 2016 update
by Cappellari, Manuel and Bovi, Paolo
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 4/2017, Volume 43, Issue 3, pp. 302 - 305
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-017-1475-3 
Medicine & Public Health | Hematology | Cardiology | PERIPHERAL VASCULAR DISEASE | THERAPY | HEMATOLOGY | ASSOCIATION | ACUTE ISCHEMIC-STROKE | Care and treatment | Usage | Anticoagulants (Medicine) | Atrial fibrillation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Continuation of direct oral anticoagulants in the acute phase of ischemic stroke. A case series
by Cappellari, Manuel and Cappellari, Manuel and Bovi, Paolo and Bovi, Paolo
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 2/2017, Volume 43, Issue 2, pp. 248 - 251
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-016-1430-8 
Medicine & Public Health | Hematology | Cardiology | PERIPHERAL VASCULAR DISEASE | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | ASSOCIATION | Stroke - pathology | Acute Disease | Administration, Oral | Brain Ischemia - drug therapy | Humans | Anticoagulants - therapeutic use | Stroke - drug therapy | Stroke (Disease) | Ischemia | Anticoagulants (Medicine)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update
by Cappellari, Manuel and Bovi, Paolo
Thrombosis and Haemostasis, ISSN 0340-6245, 2015, Volume 113, Issue 2, pp. 440 - 444
Letters to the Editor | DABIGATRAN ANTICOAGULATION | MANAGEMENT | TISSUE-PLASMINOGEN ACTIVATOR | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | SAFE | HEMATOLOGY | Dabigatran - adverse effects | Pyrazoles - therapeutic use | Humans | Middle Aged | Male | Tissue Plasminogen Activator - therapeutic use | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Dabigatran - therapeutic use | Tissue Plasminogen Activator - adverse effects | Contraindications | Kidney Function Tests | Drug Interactions | Rivaroxaban - adverse effects | Thrombolytic Therapy - methods | Aged, 80 and over | Female | Retrospective Studies | Rivaroxaban - therapeutic use | Pyrazoles - adverse effects | Cerebral Hemorrhage - chemically induced | Drug Administration Schedule | Administration, Oral | Antithrombins - therapeutic use | Endovascular Procedures | Anticoagulants - therapeutic use | Tissue Plasminogen Activator - administration & dosage | Stroke - drug therapy | Anticoagulants - adverse effects | Factor Xa Inhibitors - therapeutic use | Thrombectomy | Cerebral Hemorrhage - epidemiology | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Aged | Pyridones - therapeutic use | Infusions, Intravenous | Pyridones - adverse effects | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature
by Cappellari, Manuel and Bovi, Paolo
International Journal of Cardiology, ISSN 0167-5273, 2017, Volume 244, pp. 282 - 284
Abstract Background To date, very little is known about the effects of direct oral anticoagulants (DOA) use in patients with cervical artery dissection (CAD)... 
Cardiovascular | Cervical artery dissection | Direct oral anticoagulants | Non-vitamin K anticoagulants | New oral anticoagulants | Cerebral venous thrombosis | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITOR | Aneurysm, Dissecting - diagnosis | Venous Thrombosis - diagnosis | Anticoagulants - administration & dosage | Venous Thrombosis - drug therapy | Administration, Oral | Humans | Middle Aged | Stroke - diagnosis | Male | Treatment Outcome | Intracranial Aneurysm - diagnosis | Stroke - drug therapy | Aneurysm, Dissecting - drug therapy | Adult | Female | Intracranial Thrombosis - diagnosis | Intracranial Thrombosis - drug therapy | Retrospective Studies | Intracranial Aneurysm - drug therapy | Stroke (Disease) | Care and treatment | Thrombophlebitis | Anticoagulants (Medicine) | Analysis | Surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation
by Cappellari, Manuel and Carletti, Monica and Danese, Alessandra and Bovi, Paolo
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 10/2016, Volume 42, Issue 3, pp. 393 - 398
Direct oral anticoagulants (DOACs) are superior to warfarin in reduction of the intracranial bleeding risk. The aim of the present study was to assess whether... 
Stroke | Medicine & Public Health | Hematology | New oral anticoagulants | Non-valvular atrial fibrillation | Direct oral anticoagulants | Cardiology | Non-VKA oral anticoagulants | Cardioembolic | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | RIVAROXABAN | HEMORRHAGIC TRANSFORMATION | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Embolism - complications | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Intracranial Hemorrhages - etiology | Stroke - complications | Anticoagulants - therapeutic use | Male | Secondary Prevention | Stroke - drug therapy | Anticoagulants - adverse effects | Time Factors | Female | Aged | Retrospective Studies | Intracranial Hemorrhages - prevention & control | Stroke (Disease) | CT imaging | Warfarin | Stroke patients | Analysis | Atrial fibrillation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk: Updated meta-analysis
by Cappellari, Manuel and Bovi, Paolo
Neurology, ISSN 0028-3878, 03/2016, Volume 86, Issue 9, pp. 880 - 881
CLINICAL NEUROLOGY | Cerebral Hemorrhage - therapy | Thrombolytic Therapy - adverse effects | Fibrinolytic Agents - therapeutic use | Humans | Stroke - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Association of Baseline Hyperglycemia With Outcomes of Patients With and Without Diabetes With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Propensity Score-Matched Analysis From the SITS-ISTR Registry
by Tsivgoulis, G and Katsanos, AH and Mavridis, D and Lambadiari, V and Roffe, C and Macleod, MJ and Sevcik, P and Cappellari, M and Nevsimalova, M and Toni, D and Ahmed, N
DIABETES, ISSN 0012-1797, 09/2019, Volume 68, Issue 9, pp. 1861 - 1869
Available data from observational studies on the association of admission hyperglycemia (aHG) with outcomes of patients with acute ischemic stroke (AIS)... 
OXIDATIVE STRESS | ACTIVATION | MANAGEMENT | ALTEPLASE | SAFE IMPLEMENTATION | GLUCOSE | PREDICTORS | ENDOCRINOLOGY & METABOLISM | SYMPTOMATIC INTRACRANIAL HEMORRHAGE | ADMISSION HYPERGLYCEMIA | POSTSTROKE HYPERGLYCEMIA | Stroke (Disease) | Diabetics | Hyperglycemia | Care and treatment | Usage | Patient outcomes | Health aspects | Risk factors | Thrombolytic therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Missing data on 3-month modified Rankin Scale may influence results of functional outcome after intravenous thrombolysis in observational studies
by Forlivesi, Stefano and Cappellari, Manuel and Bovi, Paolo
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 11/2016, Volume 42, Issue 4, pp. 585 - 585
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-016-1392-x 
Medicine & Public Health | Hematology | Cardiology | HEMATOLOGY | PERIPHERAL VASCULAR DISEASE | Humans | Thrombolytic Therapy | Observational Studies as Topic | Female | Male | Stroke - therapy | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk: Updated meta-analysisAuthor Response
by Cappellari, Manuel and Charidimou, Andreas and Bovi, Paolo and Werring, David
Neurology, ISSN 0028-3878, 03/2016, Volume 86, Issue 9, pp. 880 - 881
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Letter by Cappellari et al Regarding Article, “Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-analysis of Observational Studies and Randomized Trials”
by Cappellari, Manuel and Moretto, Giuseppe and Bovi, Paolo
Stroke, ISSN 0039-2499, 06/2013, Volume 44, Issue 6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII
by Olivieri, Oliviero and Cappellari, Manuel and Turcato, Gianni and Bonetti, Bruno and Girelli, Domenico and Pizzolo, Francesca and Friso, Simonetta and Bassi, Antonella and Castagna, Annalisa and Martinelli, Nicola
Stroke, ISSN 0039-2499, 12/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Mechanical Thrombectomy for Acute Ischemic Stroke in a Patient with Concomitant Spontaneous Intracerebral Hemorrhage
by Forlivesi, Stefano, MD and Bovi, Paolo, MD and Cappellari, Manuel, MD
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2017, Volume 26, Issue 8, pp. e150 - e152
Data from randomized clinical trials and current guidelines suggest that patients with anterior circulation occlusion with contraindications to intravenous... 
Neurology | Cardiovascular | mechanical thrombectomy | large vessel occlusion | Intracerebral hemorrhage | ischemic stroke | GUIDELINES | PERIPHERAL VASCULAR DISEASE | NEUROSCIENCES | Infarction, Middle Cerebral Artery - physiopathology | Humans | Middle Aged | Treatment Outcome | Cerebrovascular Circulation | Infarction, Middle Cerebral Artery - therapy | Cerebral Angiography - methods | Cerebral Hemorrhage - physiopathology | Cerebral Hemorrhage - diagnostic imaging | Computed Tomography Angiography | Infarction, Middle Cerebral Artery - complications | Thrombectomy - methods | Female | Cerebral Hemorrhage - complications | Infarction, Middle Cerebral Artery - diagnostic imaging | Stroke (Disease) | Ischemia | Neurosciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update
by Cappellari, Manuel and Forlivesi, Stefano and Squintani, Giovanna Maddalena and Facchinetti, Roberto and Bovi, Paolo
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 5/2017, Volume 43, Issue 4, pp. 528 - 529
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11239-017-1485-1 
Medicine & Public Health | Hematology | Cardiology | HEMATOLOGY | PERIPHERAL VASCULAR DISEASE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke
by Cappellari, Manuel and Turcato, Gianni and Forlivesi, Stefano and Zivelonghi, Cecilia and Bovi, Paolo and Bonetti, Bruno and Toni, Danilo
Stroke, ISSN 0039-2499, 02/2018, Volume 49, Issue 2, pp. 397 - 404
BACKGROUND AND PURPOSE—Symptomatic intracerebral hemorrhage (sICH) is a rare but the most feared complication of intravenous thrombolysis for ischemic stroke.... 
Clopidogrel | Stroke | Calibration | Hemorrhage | Nomograms | clopidogrel | nomograms | RISK | EXTERNAL VALIDATION | SEDAN SCORE | stroke | INTRACRANIAL HEMORRHAGE | CLINICAL NEUROLOGY | THERAPY | PLASMINOGEN-ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | PROSTATE-CANCER | PERIPHERAL VASCULAR DISEASE | RETROSPECTIVE ANALYSIS | calibration | hemorrhage | Stroke (Disease) | Usage | Diagnosis | Nomography (Mathematics) | Innovations | Computational biology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage
by Seiffge, David J and Kägi, Georg and Michel, Patrik and Fischer, Urs and Béjot, Yannick and Wegener, Susanne and Zedde, Marialuisa and Turc, Guillaume and Cordonnier, Charlotte and Sandor, Peter S and Rodier, Gilles and Zini, Andrea and Cappellari, Manuel and Schädelin, Sabine and Polymeris, Alexandros A and Werring, David and Thilemann, Sebastian and Maestrini, Ilaria and Berge, Eivind and Traenka, Christopher and Vehoff, Jochen and De Marchis, Gian Marco and Kapauer, Monika and Peters, Nils and Sirimarco, Gaia and Bonati, Leo H and Arnold, Marcel and Lyrer, Philippe A and De Maistre, Emmanuel and Luft, Andreas and Tsakiris, Dimtrios A and Engelter, Stefan T and Novel Oral Anticoagulants Stroke and Novel Oral Anticoagulants in Stroke Patients study group
Annals of Neurology, ISSN 0364-5134, 03/2018, Volume 83, Issue 3, pp. 451 - 459
Objective Information about rivaroxaban plasma level (RivLev) may guide treatment decisions in patients with acute ischemic stroke (AIS) and intracerebral... 
INTRAVENOUS THROMBOLYSIS | FACTOR XA | MANAGEMENT | ORAL ANTICOAGULANTS | GUIDELINES | IV THROMBOLYSIS | COMPLICATIONS | INHIBITORS | HEALTH-CARE PROFESSIONALS | ASSOCIATION | NEUROSCIENCES | CLINICAL NEUROLOGY | Brain Ischemia - epidemiology | Cerebral Hemorrhage - drug therapy | Rivaroxaban - blood | Follow-Up Studies | Humans | Male | Stroke - drug therapy | Cerebral Hemorrhage - blood | Stroke - blood | Factor Xa Inhibitors - therapeutic use | Brain Ischemia - blood | Cerebral Hemorrhage - epidemiology | Factor Xa Inhibitors - blood | Brain Ischemia - drug therapy | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Aged | Rivaroxaban - therapeutic use | Cohort Studies | Anticoagulants | Stroke | Renal function | Thresholds | Decisions | Regression analysis | Hemorrhage | Patients | Thrombolysis | Sensitivity | Regression models | Ischemia | Correlation analysis | Plasma levels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Early function decline after ischemic stroke can be predicted by a nomogram based on age, use of thrombolysis, RDW and NIHSS score at admission
by Turcato, Gianni and Turcato, Gianni and Cervellin, Gianfranco and Cervellin, Gianfranco and Cappellari, Manuel and Cappellari, Manuel and Bonora, Antonio and Bonora, Antonio and Zannoni, Massimo and Zannoni, Massimo and Bovi, Paolo and Bovi, Paolo and Ricci, Giorgio and Ricci, Giorgio and Lippi, Giuseppe and Lippi, Giuseppe
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 4/2017, Volume 43, Issue 3, pp. 394 - 400
The availability of prediction tools for risk stratification after acute stroke is seen as a valuable perspective for tailored clinical management. This... 
Stroke | Cerebral ischemia | Medicine & Public Health | Hematology | Outcome | Nomogram | Prediction | Cardiology | Red blood cell distribution width | SURVIVAL | MATTER | CARDIAC & CARDIOVASCULAR SYSTEMS | CELL DISTRIBUTION WIDTH | PROGNOSIS | SCALE SCORE | RECOVERY | ATLANTIS | POOLED ANALYSIS | PERIPHERAL VASCULAR DISEASE | OUTCOMES | HEMATOLOGY | SEVERITY | Severity of Illness Index | Multivariate Analysis | Predictive Value of Tests | Brain Ischemia | Age Factors | Humans | Middle Aged | Stroke - complications | Male | Thrombolytic Therapy | Nomograms | Aged, 80 and over | Erythrocytes - pathology | Female | Aged | Retrospective Studies | Stroke (Disease) | Usage | Ischemia | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Circadian variation in the effect of intravenous thrombolysis after non-lacunar stroke
by Cappellari, Manuel and Bovi, Paolo and Moretto, Giuseppe
Journal of Thrombosis and Thrombolysis, ISSN 0929-5305, 8/2014, Volume 38, Issue 2, pp. 253 - 259
The onset of non-lacunar stroke symptoms has a circadian variation, with a higher risk in the early morning hours and lower risk during the nighttime period,... 
Stroke | Alteplase | Medicine & Public Health | Hematology | Outcome | Cardiology | Circadian | Thrombolysis | Fibrinolysis | TISSUE-PLASMINOGEN ACTIVATOR | TIME | TRIAL | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | EXPERIENCE | HEMATOLOGY | Follow-Up Studies | Humans | Middle Aged | Male | Stroke - drug therapy | Tissue Plasminogen Activator - therapeutic use | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Retrospective Studies | Circadian Rhythm - drug effects | Stroke (Disease) | Neurosciences | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis can change
by Cappellari, Manuel and Bovi, Paolo
International Journal of Stroke, ISSN 1747-4930, 12/2016, Volume 11, Issue 9, pp. NP91 - NP92
PERIPHERAL VASCULAR DISEASE | ISCHEMIC-STROKE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.